Bifogade filer
Interim Report Stille Q3 2025
Kurs
-3,85%
Likviditet
1,77 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2026-10-23 | 08:00 | Kvartalsrapport 2026-Q3 |
| 2026-07-23 | 08:00 | Kvartalsrapport 2026-Q2 |
| 2026-04-24 | 08:00 | Kvartalsrapport 2026-Q1 |
| 2026-02-12 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-23 | - | Kvartalsrapport 2025-Q3 |
| 2025-07-17 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-09 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2025-05-07 | - | Årsstämma |
| 2025-04-24 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-10-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-18 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-10 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2024-05-08 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-16 | - | Bokslutskommuniké 2023 |
| 2023-12-29 | - | Extra Bolagsstämma 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | - | X-dag ordinarie utdelning STIL 1.80 SEK |
| 2023-05-05 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-06 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2022-05-05 | - | Årsstämma |
| 2022-05-01 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-27 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-16 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-05 | - | X-dag ordinarie utdelning STIL 1.70 SEK |
| 2021-05-04 | - | Årsstämma |
| 2021-04-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-10-29 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-28 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2020-05-27 | - | Årsstämma |
| 2020-04-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-10-31 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-03 | - | X-dag ordinarie utdelning STIL 1.45 SEK |
| 2019-05-02 | - | Årsstämma |
| 2019-05-02 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-25 | - | Bokslutskommuniké 2018 |
| 2018-11-22 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-23 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-23 | - | X-dag ordinarie utdelning STIL 1.20 SEK |
| 2018-04-20 | - | Årsstämma |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-11-16 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-18 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-27 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2017-04-26 | - | Årsstämma |
| 2017-02-16 | - | Bokslutskommuniké 2016 |
| 2016-11-17 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-29 | - | X-dag ordinarie utdelning STIL 0.80 SEK |
| 2016-04-28 | - | Årsstämma |
| 2016-02-18 | - | Bokslutskommuniké 2015 |
| 2015-11-17 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-25 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-19 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-16 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2015-04-15 | - | Årsstämma |
| 2015-02-18 | - | Bokslutskommuniké 2014 |
| 2014-11-19 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-28 | - | Kvartalsrapport 2014-Q2 |
| 2014-07-30 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2014-05-14 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-03 | - | Årsstämma |
| 2014-02-20 | - | Bokslutskommuniké 2013 |
| 2013-11-28 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-29 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-28 | - | Kvartalsrapport 2013-Q1 |
| 2013-04-26 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2013-04-25 | - | Årsstämma |
| 2013-02-20 | - | Bokslutskommuniké 2012 |
| 2012-11-20 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-29 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-16 | - | Kvartalsrapport 2012-Q1 |
| 2012-04-19 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2012-04-18 | - | Årsstämma |
| 2012-02-15 | - | Bokslutskommuniké 2011 |
| 2011-11-16 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-24 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-18 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-14 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2011-04-13 | - | Årsstämma |
| 2011-02-16 | - | Bokslutskommuniké 2010 |
| 2010-11-24 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-18 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-16 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2010-04-15 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-19 | - | Bokslutskommuniké 2009 |
| 2009-11-20 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-27 | - | Kvartalsrapport 2009-Q2 |
| 2009-05-15 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2009-05-14 | - | Kvartalsrapport 2009-Q1 |
| 2009-04-15 | - | Årsstämma |
| 2008-06-24 | - | Split STIL 100:1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Revenue amounted to 138.8 MSEK (127.9), an increase of 8.5 percent, of which a negative organic growth of 1.9 percent. The quarter was negatively impacted by the phase-out of non-strategic products in surgical instruments that began in early 2025 and a negative currency effect. Adjusted for these two factors, underlying organic growth would have amounted to 7.3 percent.
“We had a continued strong demand and acquisition-driven sales growth in a quarter characterized by negative currency effects and stabilization of the supply chain” says Ulrik Berthelsen. “Looking ahead to 2026, we anticipate a return to growth driven by a combination of strong order intake, operational improvements and commercial execution.”
The gross profit margin in the quarter amounted to 48.8 percent (53.1) and EBIT before non-recurring items amounted to 17.3 MSEK (24.4).
| MSEK | JUL–SEP 2025 | JUL–SEP 2024 | JAN–SEP 2025 | JAN–SEP 2024 | OCT–SEP 2024/2025 | JAN–DEC 2024 |
| Net sales | 138.8 | 127.9 | 392.7 | 408.7 | 554.0 | 569.9 |
| Gross profit, % | 48.8 | 53.1 | 50.6 | 49.3 | 52.1 | 51.9 |
| EBITDA before non-recurring items | 26.1 | 31.3 | 75.7 | 96.2 | 122.0 | 142.4 |
| EBITDA before non-recurring items, % | 18.8 | 24.5 | 19.3 | 23.5 | 22.0 | 25.0 |
| EBITDA | 19.0 | 31.3 | 68.6 | 76.1 | 90.5 | 98.0 |
| EBITDA, % | 13.7 | 24.5 | 17.5 | 18.6 | 16.3 | 17.2 |
| EBIT before non-recurring items | 17.3 | 24.4 | 51.8 | 75.7 | 91.0 | 114.9 |
| EBIT before non-recurring items, % | 12.5 | 19.1 | 13.2 | 18.5 | 16.4 | 20.2 |
| EBIT | 10.3 | 24.4 | 44.7 | 55.7 | 59.5 | 70.5 |
| EBIT, % | 7.4 | 19.1 | 11.4 | 13.6 | 10.7 | 12.4 |
This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-10-23 08:00 CEST.
Contact Details
Ulrik Berthelsen
CEO & President
+46 (0)73 033 38 25 | ulrik.berthelsen@stille.se
About Us
Stille AB (publ) is a well-established pioneer in the development, manufacturing and distribution of premium surgical instruments and advanced surgical tables, with a differentiated offering in fast growing niche markets for high-precision procedures. Stille was founded in 1841 and is listed on Nasdaq First North Growth Market under the ticker “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, +46 8 684 211 10, adviser@eminova.se. More information is available at www.stille.se.
Attachments
Interim Report Stille Q3 2025